Making a Difference, Here & Beyond
The community invests in Dell Med. In return, it’s our responsibility — one we take seriously — to be agents for change and to show real impact.
More Information
Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
More Information
Let’s Do Big Things Together
True health demands that the whole work in harmony, which is why we’re dedicated to partnership. Indeed, we can’t achieve our goals without it.
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
More Information
Make an Appointment Directory Give Faculty Students

Parker Expert Lecture Series

Location: Virtual

Date: Tuesday, May 4, 2021

Time: 12–1 p.m.

Contact: Renee Collins

About the Event

This installment of Parker Expert Lecture Series features Joan A. Camprodon, M.D., MPH, Ph.D., presenting “Neuropsychiatry and Neuromodulation: Circuit-Based Strategies for Biomarker Discovery and Treatment Development.” Camprodon is Chief of the Division of Neuropsychiatry at Massachusetts General Hospital, the founding director of the Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology). He is board-certified in Psychiatry, and Behavioral Neurology & Neuropsychiatry.

Email Renee Collins for the Zoom information.

Learning Objectives

By the end of this presentation, the audience participant should be able to:

  • Recognize the full spectrum of device neuromodulation therapies.
  • Characterize the clinical outcomes of individualized image-guided TMS.
  • Characterize circuit-based predictors of response and mechanism of action of individualized image-guided TMS.

Target Audience

  • Primary: Psychiatrists, Social Workers, Psychologists, Nurses and other Mental Health Professionals
  • Secondary: Other health care professionals


This activity has been designed to promote some of the following desired physician attributes and competencies:

  • ACGME: Patient Care, Professionalism, Medical Knowledge, Practice-based Learning and Improvement
  • IOM: Patient-Centered Care,Work w/Interdisciplinary Teams, Use Evidence-based Practice
  • IECC: Interprofessional Teamwork & Team-based Practice, Interprofessional Communication, Roles and Responsibilities

Speaker Disclosure

Camprodon, speaker for this educational activity, is a consultant for Neuronetics and on the Scientific Advisory Board for Hyka Therapeutics and Feelmore Labs.

Planner Disclosure

Jorge Almeida, M.D., Ph.D., and Renee Collins, the planners for this educational activity, do not have relevant financial relationship(s)with ineligible companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.

Accreditation Statement

The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.